東亜薬品株式会社 (Corporate ID: 6230001001811) is a large corporation operating in the 建設業 sector headquartered in 富山県富山市三郷２６番地. Led by 代表取締役 中井淳. Latest operational metrics report workforce: 570 employees, capital: ¥561M JPY. Fully registered under Japan's National Tax Agency Qualified Invoice System (Invoice No: T6230001001811). Official contact (076-478-5100), corporate governance, and multi-year financial statements are openly accessible on Kigyou-list.
Official change history records regarding corporate name, registered address, and legal entity designations synced with Japan National Tax Agency (国税庁).
13-digit Corporate Number "6230001001811" was officially assigned by the National Tax Agency Commissioner with corporate name "東亜薬品株式会社".
Cross-check reviews, press releases, and compliance background across top Japanese portals.
The official representative phone number for 東亜薬品株式会社 is 076-478-5100 (FAX: 076-478-5142). Head office is located at 富山県富山市三郷２６番地. Verified contact channels and executive directories are accessible on Kigyou-list.
東亜薬品株式会社's official 13-digit National Tax Agency Corporate Number is 6230001001811. It is officially registered as a Qualified Invoice Issuer under Japan's consumption tax invoice system with registration ID T6230001001811.
東亜薬品株式会社 is officially registered and headquartered at Postal Code 9390000, 富山県富山市三郷２６番地. Complete regional jurisdiction and legal relocation history are verified via Japan's National Tax Agency.
Outreach to 東亜薬品株式会社 or acquire targeted lookalike company datasets.
東亜薬品株式会社に関連する公的異動登記および富山県の各カテゴリ別データベースへの直通インデックスです。 最新の法人登記データや採用活動の動向を各ハブにて毎日自動更新しています。
※ Corporate information on this profile is aggregated, verified, and structured based on official open data provided by the National Tax Agency (国税庁) and METI gBizINFO.
東亜薬品株式会社 currently employs 570 personnel. Most recently reported annual revenue stands at undisclosed.
The official representative of 東亜薬品株式会社 is 代表取締役 中井淳, with a registered capital of ¥561M JPY. It is privately held.
On Kigyou-list, users can review verified financial metrics, legal registry history, corporate signals (hiring, subsidies, trademarks), and export standardized CSV datasets for B2B intelligence.